Danielle Fontaine
Affiliations: | 2010-2016 | Medicine/Endocrinology | University of Wisconsin, Madison, Madison, WI |
Google:
"Danielle Fontaine"
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Kim HT, de Souza AH, Umhoefer H, et al. (2021) Cholecystokinin Attenuates β-Cell Apoptosis in both Mouse and Human Islets. Translational Research : the Journal of Laboratory and Clinical Medicine |
| Yang GH, Fontaine DA, Lodh S, et al. (2021) TCF19 Impacts a Network of Inflammatory and DNA Damage Response Genes in the Pancreatic β-Cell. Metabolites. 11 |
| Blumer JT, Han JY, Yang GH, et al. (2020) Tcf19 Knockout Mouse Islets Have Increased Stress‐related Gene Expression and Reduced Proliferative Capacity The Faseb Journal. 34: 1-1 |
| YANG GH, HAN JY, LODH S, et al. (2019) 366-OR: TCF19 Promotes Functional Beta-Cell Mass and Proliferative Capacity by Regulating DNA Damage Repair Pathways Diabetes. 68: 366-OR |
| Neuman JC, Schaid MD, Brill AL, et al. (2017) Enriching Islet Phospholipids with Eicosapentaenoic Acid Reduces Prostaglandin E2 Signaling and Enhances Diabetic β-cell Function. Diabetes |
| Baan M, Krentz KJ, Fontaine DA, et al. (2016) Successful in vitro fertilization and generation of transgenics in Black and Tan Brachyury (BTBR) mice. Transgenic Research |
| Fontaine DA, Davis DB. (2016) Attention to Background Strain Is Essential for Metabolic Research: C57BL/6 and the International Knockout Mouse Consortium. Diabetes. 65: 25-33 |
| Krautkramer KA, Linnemann AK, Fontaine DA, et al. (2013) Tcf19 is a novel islet factor necessary for proliferation and survival in the INS-1 β-cell line. American Journal of Physiology. Endocrinology and Metabolism. 305: E600-10 |